Search Within

Human Oncology and Pathogenesis Program

Formats
  1. Journal Article (3016)
  2. Meeting Abstract (2565)
  3. Review (137)
  4. Editorial (107)
  5. Book Section (54)
  6. Research Letter (42)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (16)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. GSK Faculty (5769)
  2. Department of Medicine (4320)
  3. Department of Pathology and Laboratory Medicine (3070)
  4. Tow Center for Developmental Oncology (TCDO) (2639)
  5. Solid Tumor Oncology Division (2634)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2584)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Ross Levine (786)
  3. David Solit (781)
  4. Michael Berger (769)
  5. Nikolaus Schultz (491)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (171)
  2. 2024 (381)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (649)
  2. Blood (517)
  3. Cancer Research (413)
  4. Modern Pathology (300)
  5. Clinical Cancer Research (269)
  6. Laboratory Investigation (265)

More Publications

Publishers
  1. American Association for Cancer Research (876)
  2. Nature Publishing Group (767)
  3. American Society of Clinical Oncology (717)
  4. American Society of Hematology (564)
  5. Elsevier Inc. (420)
  6. Nature Research (314)

More Publishers

Results (5987)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular biology of novel targets identified through study of castration-recurrent prostate cancer
    Book Section

    Watson, P. A.; Sawyers, C. L.
    In Tindall, D.; Mohler, J. (Eds.) Androgen Action in Prostate Cancer (2009)

    Fulltext@MSK | Save
  • Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer
    Journal Article

    Welsbie, D. S.; Xu, J.; Chen, Y.; Borsu, L.; Scher, H. I.; Rosen, N.; Sawyers, C. L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Development of a second-generation antiandrogen for treatment of advanced prostate cancer
    Journal Article

    Tran, C.; Ouk, S.; Clegg, N. J.; Chen, Y.; Watson, P. A.; Arora, V.; Wongvipat, J.; Smith-Jones, P. M.; Yoo, D.; Kwon, A.; more...
    Science (2009)

    Fulltext@MSK | Save
  • Genetic predictors of MEK dependence in V600E BRAF mutant melanoma
    Meeting Abstract

    Xing, F.; Pratilas, C.; Persaud, Y.; Janakiraman, M.; Houghton, A.; Rosen, N.; Solit, D.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Breast tumor cells with PI3K mutation or HER2 amplification are selectively dependent on Akt signaling
    Meeting Abstract

    She, Q. B.; Chandarlapaty, S.; Ye, Q.; Lobo, J.; Haskell, K.; Leander, K.; DeFeo-Jones, D.; Huber, H.; Rosen, N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The functional analysis of a novel KDR (VEGFR II)-PDGFR-alpha fusion gene in glioblastoma: From discovery to clinical application
    Meeting Abstract

    Ozawa, T.; Brennan, C. W.; Normand, G.; Wang, L.; Antczak, C.; Shum, D.; Tandon, A.; Fomchenko, E.; Squatrito, M.; Levine, R. L.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
    Meeting Abstract

    King, J. C.; Xu, J.; Wongvipat, J.; Hieronymus, H.; Leung, D. H.; Taylor, B. S.; Sander, C.; Cardiff, R. D.; Couto, S. S.; Gerald, W. L.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Identification and biological characterization of exon 4 KRAS mutations by MALDI-TOF Mass Spectrometry based genotyping
    Meeting Abstract

    Janakiraman, M.; Zeng, Z.; Chitale, D.; Halilovic, E.; Rosen, N.; Vakiani, E.; Heguy, A.; Ladanyi, M.; Jhanwar, S.; Saltz, L.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • The cell origin of hematopoietic malignancies
    Meeting Abstract

    Haeno, H.; Levine, R.; Gilliland, G.; Michor, F.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Endogenous expression of oncogenic Braf cooperates with Pten loss to induce poorly differentiated thyroid cancers with complete penetrance and early lethality
    Meeting Abstract

    Franco, A. T.; Malguarnera, R.; Kimura, S.; Pritchard, C.; Marais, R.; Ghossein, R.; Fagin, J. A.
    Cancer Research (2009)

    Fulltext@MSK | Save